Spatial Genomics & Transcriptomics Market worth $1.23 billion in 2031
The report "Spatial Genomics & Transcriptomics Market by Product (Instrument, Consumable, Service), Technique (Transcriptomics [IHC, ISH, RNA Sequencing], Genomics [LCM]), Service Type (Sample Prep, Analytical), Application (Drug Discovery) - Global Forecast to 2031" is expected to be valued at USD 0.67 billion in 2026 and USD 1.23 billion in 2031, recording a CAGR of 12.9% during the forecast period.
Browse 600 market data Tables and 57 Figures spread through 451 Pages and in-depth TOC on "Spatial Genomics & Transcriptomics Market by Product (Instrument, Consumable, Service), Technique (Transcriptomics [IHC, ISH, RNA Sequencing], Genomics [LCM]), Service Type (Sample Prep, Analytical), Application (Drug Discovery) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/spatial-genomics-transcriptomics-market-170900551.html
The market is experiencing significant growth, driven by the rising use of spatial profiling in oncology, precision medicine, drug discovery, and biomarker research. Pharmaceutical and biotechnology companies are increasingly adopting technologies such as spatial transcriptomics, in-situ hybridization, sequencing-based spatial analysis, and high-plex molecular imaging to study gene expression, cellular interactions, tissue architecture, and disease progression. The growing focus on single-cell analysis, multi-omics integration, and AI-enabled spatial data interpretation is further supporting market expansion, particularly across cancer research, translational research, and personalized medicine. However, the market continues to face challenges such as high instrument and consumable costs, complex spatial data analysis, variability across platforms, and difficulties in standardizing workflows across research and clinical applications.
Products market held the largest share of the spatial genomics & transcriptomics market in 2025.
By offering, the spatial genomics & transcriptomics market is categorized into products and services. In 2025, products accounted for the largest market share, driven by the widespread use of instruments, assay kits, reagents, probes, and consumables in spatial profiling workflows. These products support gene expression analysis, tissue mapping, cellular interaction studies, biomarker discovery, and disease research. Their recurring use across pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations contributes to sustained demand. Increasing adoption of spatial transcriptomics and high-resolution molecular imaging technologies further supports the leading position of products in the market.
Sample preparation services to grow at the highest CAGR between 2026 and 2031.
By type, the sample preparation services segment is expected to grow at the highest CAGR in the spatial genomics & transcriptomics market during the forecast period, driven by the increasing need for high-quality tissue processing, fixation, embedding, sectioning, and sample preservation before spatial molecular analysis. Growing adoption of spatial transcriptomics in oncology, neuroscience, immunology, and biomarker discovery is increasing demand for specialized sample preparation workflows. Pharmaceutical and biotechnology companies, academic institutes, and research organizations are increasingly relying on specialized service providers to manage complex tissue samples and improve experimental reproducibility. These factors are expected to support demand for sample preparation services as spatial genomics and transcriptomics research expands.
Asia Pacific to register the highest CAGR in the spatial genomics & transcriptomics market from 2026 to 2031.
By region, Asia Pacific is expected to witness the fastest market growth during the forecast period, driven by expanding genomics research, increasing investments in precision medicine, and growing adoption of advanced spatial profiling technologies. China, Japan, South Korea, and India are strengthening their life sciences research capabilities through government initiatives, expanding biotechnology infrastructure, and increasing pharmaceutical R&D investments. The presence of regional players, including BGI Genomics Co., Ltd. (China), Takara Holdings Inc. (Japan), and Macrogen, Inc. (South Korea), supports market development through genomics platforms, molecular analysis capabilities, and research services. Growing applications in oncology, neuroscience, immunology, and biomarker discovery, alongside collaborations between academic institutions, biotechnology companies, and pharmaceutical organizations, are expected to accelerate the adoption of spatial genomics and transcriptomics technologies across the region.
Some of the leading players in the spatial genomics & transcriptomics market include 10x Genomics (US), Bio- Techne (US), Bruker (US), Standard BioTools Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Visiopharm A/S (Denmark), Danaher Corporation (US), Velsera Inc. (US), and Revvity, Inc. (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Spatial Genomics & Transcriptomics Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
